ArticleCase reports in medicine2025
Thrombotic Microangiopathy (TMA) in a Heart Transplant Patient: A Complex Clinical-Pathologic Dilemma.
Article in Case reports in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced thrombotic microangiopathy is a rare cause of microangiopathic hemolytic anemia. Tacrolimus is a commonly used immunosuppressive agent postorgan transplant. Due to life-threatening complications associated with microangiopathic hemolytic anemia, it is essential to have a high clinical suspicion for this drug-induced microangiopathy. Here, we present a case of suspected drug-induced thrombotic microangiopathy secondary to long-term tacrolimus use. Although it is difficult to entirely exclude alternative causes of TMA when presented with this rare pathology, clinicians must remain vigilant of this association with tacrolimus use when there is a high suspicion for TMA. To date, few case reports have highlighted this association with chronic calcineurin use. Our case highlights the need for further research into this association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.